Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonance HealthASX:RHT +7.69% EV-to-EBIT is 47.58 as of Jul. 28, 2026. The stock has 8 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Resonance Health ranks worse than 87.47% on this metric.
The historical rank and industry rank for Resonance Health's EV-to-EBIT or its related term are showing as below:
ASX:RHT'
s EV-to-EBIT Range Over the Past 10 Years
Min: -202.25 Med: -12.36 Max: 396.28
Current: 47.58
During the past 13 years, the highest EV-to-EBIT of Resonance Health was 396.28. The lowest was -202.25. And the median was -12.36.
ASX:RHT's EV-to-EBIT is ranked worse than 87.47% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs ASX:RHT: 47.58
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Resonance Health's Enterprise Value for the quarter that ended in Dec. 2025 was A$24.62 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Resonance Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health EV-to-EBIT Related Terms
Resonance Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Resonance Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Resonance Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Resonance Health's EV-to-EBIT falls into.
Resonance Health's current Enterprise Value is A$26.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Resonance Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health (ASX:RHT) has a EV-to-EBIT of 47.58 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Resonance Health and its competitors. According to the industry distribution chart, Resonance Health ranks #412 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 87.5%.
Is Resonance Health's EV-to-EBIT too high?
Resonance Health's current EV-to-EBIT is 47.58. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Resonance Health's value of 47.58 is 199.8% above this industry median. Based on the distribution chart, Resonance Health ranks #412 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Resonance Health's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #412 out of 471 companies for EV-to-EBIT. This places Resonance Health in the lower half of its industry. The industry median EV-to-EBIT is 15.87. Resonance Health's value of 47.58 is 199.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Health's current EV-to-EBIT of 47.58 is 199.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current EV-to-EBIT is 47.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.06 — trading 53.3% below its estimated fair value. The current EV-to-EBIT is 47.58 and 199.8% above the Healthcare Providers & Services industry median of 15.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current EV-to-EBIT is 47.58 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 
